Description

Retabolil (Nandrolone Decanoate) Solution for Injections 50 mg/ml. 1ml. Ampoule №1

Ingredients:

Each 1ml ampoule contains 50mg of Nandrolone Decanoate as the active ingredient.

Dosage:

The usual dosage is 50-200mg every 1-4 weeks, administered by intramuscular injection.

Indications:

Retabolil is indicated for the management of anemia associated with renal insufficiency, and as supportive therapy for osteoporosis.

Contraindications:

Do not use Retabolil in case of prostate cancer, breast cancer in men, hypercalcemia, or hypersensitivity to the drug.

Directions:

Administer the injection deeply into the gluteal muscle. Rotate injection sites to prevent irritation.

Scientific Evidence:

Nandrolone Decanoate, the active ingredient in Retabolil, has been extensively studied for its efficacy in treating anemia and osteoporosis. Research published in the Journal of Clinical Endocrinology & Metabolism demonstrated that nandrolone decanoate significantly increased hemoglobin levels in patients with chronic renal failure, improving their quality of life.

Additional Information:

It is important to monitor liver function tests during treatment with Retabolil due to the potential for hepatic side effects. Additionally, regular monitoring of prostate-specific antigen (PSA) levels is recommended in patients receiving nandrolone therapy.

Pharmacological Effects:

Nandrolone Decanoate exerts its effects by increasing red blood cell production, enhancing bone density, and promoting muscle growth. It acts by binding to androgen receptors in the body, stimulating protein synthesis and nitrogen retention, leading to anabolic effects.

Clinical Trials and Comparative Effectiveness:

In a comparative study published in the Journal of Bone and Mineral Research, nandrolone decanoate was found to be more effective in increasing bone mineral density compared to other anabolic agents in postmenopausal women with osteoporosis. The study highlighted the superior bone-protective effects of nandrolone decanoate.